Alexza to report on November 5

• Alexza Pharmaceuticals (NASDAQ:ALXA -2.6%) will report Q3 results on November 5 after the close. The conference call will begin at 5:00 m ET.
• Consensus view is a loss of ($0.77) per share on revenues of $3.2M.